<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01970735</url>
  </required_header>
  <id_info>
    <org_study_id>13-AOI-01</org_study_id>
    <nct_id>NCT01970735</nct_id>
  </id_info>
  <brief_title>Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2</brief_title>
  <official_title>Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to compare the severity of illness between groups of patients
      (Facio-Scapulo-Humeral Dystrophy = FHSD1, FSHD2 and patients both FSHD1 and FSHD2).

      Despite advances in research on the subject, answers are still needed on these diseases.

      We also aim to determine whether the chromosomal genetic abnormality is involved in other
      diseases and the frequency of this mutation in the population of patients FSHD.

      This study will increase our knowledge of the two forms of FSHD who present a common
      pathophysiological mechanism and may occur together in the same family with a worsening of
      the clinical phenotype worsening . In addition, epigenetic differences between FSHD type 1
      and type 2 seems to have clinical consequences requiring appropriate management
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle damage measure</measure>
    <time_frame>One time at the inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of muscle damage</measure>
    <time_frame>One time at the inclusion</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Muscular Dystrophy, Facioscapulohumeral</condition>
  <arm_group>
    <arm_group_label>FSHD patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <arm_group_label>FSHD patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 18 years and &lt;75 years

          -  FSHD patients 1 or 2 with or without genetic confirmation

        Exclusion Criteria:

        - Patient with all conditions considered by the investigator interfering with the proper
        conduct of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sabrina SACCONI, Dr</last_name>
    <phone>+33 492039002</phone>
    <email>sacconi.s@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Archet 1</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina SACCONI, Dr</last_name>
      <phone>+33 492039002</phone>
      <email>sacconi.s@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Sabrina SACCONI, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2013</study_first_submitted>
  <study_first_submitted_qc>October 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2013</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Facioscapulohumeral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

